To explore the universal law of the abnormal gene expression and the structural variation of genes related to lung adenocarcinoma, the gene expression profile of GSE37765 were downloaded from Gene Expression Omnibus database. The differentially expressed genes (DEGs) were analyzed with t-test and NOISeq tool, and the core DEGs were screened out by combining with another RNA-seq data containing totally 77 pairs of samples in 77 patients with lung adenocarcinoma. Moreover, the functional annotation of the core DEGs was performed by using the Database for Annotation Visualization and Integrated Discovery following selection of oncogene and tumor suppressor by combining with tumor suppressor genes and Cancer Genes database, and motif-finding of core DEGs was performed with motif-finding algorithm Seqpos. We also used Tophat-fusion tool to further explore the fusion genes. In total, 850 downregulated DEGs and 206 upregulated DEGs were screened out in lung adenocarcinoma tissues. Next, we selected 543 core DEGs, including 401 downregulated and 142 upregulated genes, and vasculature development (P ¼ 1.89E À 06) was significantly enriched among downregulated core genes, as well as mitosis (P ¼ 6.26E À 04) enriched among upregulated core genes. On the basis of the cellular localization analysis of core genes, wnt-1-induced secreted protein 1 (WISP1) and receptor (G protein-coupled) activity modifying protein 1 (RAMP1) identified mainly located in extracellular region and extracellular space. We also screened one oncogene, v-myb avian myeloblastosis viral oncogene homolog-like 2 (MYBL2). Moreover, transcription factor GATA2 was mined by motif-finding analysis. Finally, four fusion genes belonged to the human leukocyte antigen (HLA) family. WISP1, RAMP1, MYBL2 and GATA2 could be potential targets of treatment for lung adenocarcinoma and the fusion of HLA family genes might have important roles in lung adenocarcinoma.
INTRODUCTION
Lung cancer is the most leading cause of cancer deaths in both men and women worldwide, 1, 2 and also is the leading cause of cancer-related death in the United States.
3 Approximately 1.2 million new cases are diagnosed each year and their prognoses are poor. 4 Despite advances in treatment, such as combination chemotherapy and chemoradiation, survival rate has improved very little over the past few decades. 5 Lung adenocarcinoma is the most common form of lung cancer and has an average 5-year survival rate of 15%, mainly because of late-stage detection and a paucity of late-stage treatments. 6 For lung adenocarcinoma, there were some studies focused on the analysis of potential mechanism up to now. For example, Beer et al. reported that a set of genes were screened out by using microarray analysis and they could predict survival in earlystage lung adenocarcinoma, such as vascular endothelial growth factor, cystatin C epidermal growth factor receptor 2 erbB2 and oncogene crk and so on. 7 In addition, frequently mutated genes, including tyrosine kinases, multiple ephrin receptor genes EPHA3 and epidermal growth factor receptor homologue ERBB4, were detected in human lung adenocarcinomas. 6 Moreover, the overexpression of antioxidant enzyme AOE372, ATP synthase subunit d and other proteins were identified with two-dimensional polyacrylamide gel electrophoresis and mass spectrometry in lung adenocarcinoma. 8 However, the specific mechanism is not confirmed in the development of lung adenocarcinomas and the abnormalities related to carcinogenesis need urgent research in detail. Recently, microarray analysis has been considered as the most comprehensive method to detect gene expression and find significant advances in lung adenocarcinoma. 9 However, microarray analysis also has several limitations, including probe hybridization kinetics, probe selection and background hybridization, which may limit the ability to accurately estimate low-level transcripts and cross-platform comparability. 10 Although transcriptome sequencing has been shown to be comparable to microarrays, 11 it has potential advantages, such as a larger dynamic range, the ability to detect all expressed transcripts as a function of depth of read coverage and the ability to detect the structure of transcripts. 12, 13 Besides, transcriptome sequencing analysis has been usually used to investigate genetic variation, 14 transcription factor binding sites 15 and DNA methylation. 16 In this study, we used high-throughput mRNA sequencing (RNA-Seq) to characterize the differences and similarities of transcriptome expression in patients with lung adenocarcinoma by comparing with healthy controls, to determine the universal law of the abnormal genes expression in lung adenocarcinoma tissues. In addition, based on the high resolution of RNA-Seq database, we also detected the fusion gene in each lung adenocarcinoma sample, attempting to explore the structural variation of genes related to lung adenocarcinoma.
MATERIALS AN METHODS

Sample data source
The set of gene expression profile GSE37765 (ref. 17) was downloaded from the public functional genomics database Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/). The pairs of samples were designed and each pair of lung adenocarcinoma sample and normal lung sample was obtained from primary lung adenocarcinoma tumor and adjacent noncancerous lung tissue of each patient, respectively. All patients were diagnosed with lung cancers for the first time. None of the patients had distant metastasis or family history of lung cancer. Next, six lung adenocarcinoma samples (GSM927309, GSM927311, GSM927313, GSM927315, GSM927317 and GSM927319) and six normal lung samples (GSM927308, GSM927310, GSM927312, GSM927314, GSM927316 and GSM927318) were selected from this set of data. The Illumina Genome Analyzer IIx platform (Illumina, San Diego, CA) was used for sequencing with paired-end reads sequencing method.
Comparing the RNA-seq data and calculating the expression values of genes The comparison of reads was performed with Tophat software 18 based on hg19 reference sequences RNA-Seq downloaded from the UCSC Genome Browser (http://genome.ucsc.edu). During the comparison, the unique result of reads and o2 base mismatch were required, and other parameters were set with the default setting of the Tophat software. After finishing the comparison, the transcriptome of each sample was assembled and the expression values of genes were calculated with Cufflinks and Cuffdiff tools, 19 according to the combination with the information of reference sequence gene annotation. In addition, the result of expression was built on the fragments per kilobase of transcript per million fragments mapped method. 20 
Analysis of the differentially expressed genes
We used two methods, t-test and NOISeq, to explore the differential transcripts between the lung adenocarcinoma samples and normal lung samples, respectively. First, all data of 12 samples were integrated, and paired t-test was applied to analyze the differentially expressed transcripts, which differentially expressed in the lung adenocarcinoma samples; the thresholds of significance were set as Po0.01 and fold change not o2. Second, the NOISeq, which is a novel nonparametric approach for the identification of differentially expressed genes (DEGs), 21 was used to detect the differentially expressed transcripts in single lung adenocarcinoma sample and normal lung sample, and the NOISeq q-valueX0.8 was demanded in each differentially expressed transcript, as well as the fold change among samples also not o2.
To further explore the core DEGs among the DEGs in lung adenocarcinoma, we combined another RNA-seq data, 22 which contained totally 77 pairs of samples in 77 patients with lung adenocarcinoma. In addition, the specifically and highly expressed factors among the core DEGs of lung adenocarcinoma were screened out with cellular localization analysis. In addition, in order to research the possibility of these highly expressed factors as the marker of identification the occurrence of lung adenocarcinoma, Gene Pattern database was combined to observe the expression levels of these factors in different type of the normal tissues.
Functional annotation of the DEGs DAVID (Database for Annotation, Visualization and Integrated Discover) 23 was chosen to analyze the function of the DEGs based on the default in DAVID (Count ¼ 2, EASE ¼ 0.1), including three aspects: biological process, molecular function and cellular component. Next, the DEGs, which possessed the function of transcriptional regulation, were screened out and marked. Finally, the known oncogenes and tumor suppressor genes among the DEGs were selected combining with the relevant cancer database: tumor suppressor genes 24 and cancer genes. 25 Predicting the upstream regulatory elements of the DEGs
The DEGs we obtained before were divided into upregulated and downregulated genes. Here we defined the region within 1 kb upstream transcription start site of the gene as the promoter region. Next, motif finding was performed in the promoter region of the upregulated and downregulated genes with a new motif-finding algorithm Seqpos, 26 to predict the transcription factor with the regulatory function on the upregulated and downregulated DEGs, with the criterion of Po0.00001 in motif-finding analysis of each promoter.
Detecting fusion genes
Tophat-fusion is an algorithm designed to discover transcripts representing fusion gene products. 27 We used Tophat-fusion tool to further explore Lung adenocarcinoma by RNA-seq
the fusion genes among the DEGs, with the number of spanning reads, supporting mate pair and supporting mate pair with spanning reads all not o20 in the predicted fusions, as well as the number of contradicting reads 0. Besides, the predicted fusion genes in normal human tissue was seen as the false-positive result, and the false-positive results in lung adenocarcinoma samples were estimated as far as possible. For the fusion genes that existed on one chromosome, the 10-kb minimum distance was considered as a compromise that allows Tophat-fusion to detect intrachromosomal rearrangements; inversions might be also included in intrachromosomal fusions.
RESULTS
Screening of DEGs in lung adenocarcinoma samples
In total, 1169 differentially expressed transcripts were identified in lung adenocarcinoma samples by paired designing in 12 samples of the two groups, containing 6 lung adenocarcinoma samples and 6 normal lung samples; there were 951 downregulated transcripts and 218 upregulated transcripts, which corresponded to 850 downregulated DEGs and 206 upregulated DEGs, respectively.
Function annotation of the DEGs Gene Ontology functional enrichment analysis was performed for all DEGs. The result showed that the downregulated genes were enriched in the vasculature development (P ¼ 1.07E À 12), cell adhesion (P ¼ 3.93E À 08) and cell proliferation (P ¼ 5.26E À 08).
For the cellular component, there was 35% downregulated genes located in the plasma membrane (P ¼ 5.13E À 12) and extracellular region (P ¼ 7.32E À 09, Table 1 ), whereas among the upregulated genes in lung adenocarcinoma samples we found that upregulated genes were significantly clustered in the mitotic cell cycle (P ¼ 3.59E À 04). For the location of these genes, Golgi apparatus (P ¼ 0.002188962) and chromosomal part (P ¼ 0.008479627) were the most significant location. In addition, the function of the upregulated genes mainly focused on the nucleoside binding (P ¼ 0.002333555) and ATP binding (P ¼ 0.007159416, Table 1 ).
Selection of core DEGs and functional analysis Combining with another RNA-seq data, 22 totally 77 pairs of samples in 77 patients with lung adenocarcinoma were included. In total, 401 genes were downregulated in the lung adenocarcinoma tissues obviously; meanwhile, another 142 genes were significantly activated in lung adenocarcinoma tissues. These 543 genes, which were differentially expressed both in lung adenocarcinoma tissues and other lung adenocarcinoma samples, were defined as core DEGs associated with lung adenocarcinoma.
Through functional enrichment analysis, the downregulated core genes were also enriched in vasculature development, cell adhesion and regulation of cell proliferation. Besides, the new biological process were enriched, such as response to wounding (P ¼ 1.17E À 04) and enzyme-linked receptor protein signaling pathway (P ¼ 3.03E À 04, Table 2 ), whereas among upregulated core genes mitosis was significantly enriched in the biological process (P ¼ 6.26E À 04). For the molecular function, these genes were also associated with nucleoside binding (P ¼ 1.81E À 01) and ATP binding (P ¼ 4.18E À 01). 
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In addition, totally eight specifically and highly expressed factors of lung adenocarcinoma were found with cytological position analysis, including WFDC2 (WAP four-disulfide core domain protein 2), WISP1 (Wnt-1-induced secreted protein 1), CST4 (cystatin S), MUC20 (mucin 20), PRDX4 (peroxiredoxin 4), RAMP1 (receptor (G protein-coupled) activity modifying protein 1), SPINT2 (serine protease inhibitor Kunitz-type 2) and transforming growth factor-a (Table 3 ). The comparative result of expression Figure 1 . Heat map of the differentially expressed genes in 83 patients with lung adenocarcinoma. Red color represents the genes expression corresponding to 6 sets of primary data, blue color represents the gene expression of the additional 77 sets of data. Red arrow displayed the upregulated core genes and green arrow displayed the downregulated core genes. 
levels of these specifically and highly expressed factors showed that SPINT2 highly expressed in the colon, hypothalamus, kidney, lung and testis; SPINT2 could not be an independent candidate of blood test indicators in lung adenocarcinoma ( Figure 1 and Figure 2 ). It is worth noting that the expression levels of WISP1, mucin 20, RAMP1 were very low in normal lung tissue, and WISP1 and RAMP1 were scarcely expressed. Hence, we thought that WISP1 and RAMP1 could be candidates of biopsy indicator to identify normal lung tissue and lung adenocarcinoma tissue.
Tumor suppressor genes and oncogenes in the core DEGs To detect the genes related to cancer diseases among core DEGs, the Cancer Gene database was used to find the ratio of known tumor suppressor and oncogene in the differentially upregulated and downregulated genes, respectively. Among the downregulated genes, totally 33 tumor suppressor genes and 13 oncogenes were detected (Table 4) , and the ratio to the downregulated core genes was 8.2% (33/401) and 3.2% (13/401), respectively, whereas among the upregulated genes the ratio of tumor suppressor genes and oncogenes were 4.2% (6/142) and 2.1% (3/142), respectively. There was no significant difference in tumor suppressor genes and oncogenes between upregulated and downregulated genes (Fisher's exact test, P ¼ 0.7097), no tumor suppressor genes significantly enriched in downregulated genes and no oncogenes obviously enriched in upregulated genes. This result suggested that tumor suppressor genes and oncogenes had no specific pattern, and the abnormal expression of the genes in lung adenocarcinoma tissues was possibly associated with the dysfunction of individual genes. Furthermore, the core DEGs, which possessed the function of transcription factor, were screened out by combining with transcription factor database. Finally, 26 transcription factors were found in downregulated genes, but only one genes v-myb avian myeloblastosis viral oncogene homolog-like 2 (MYBL2) possessed transcriptional regulatory function in 143 upregulated genes (Table 5 ). MYBL2 was also a known oncogene, and the patients with differentially upregulated expression of MYBL2 in cancer tissues were 51.8% (43/83) of all included patients.
Prediction of the upstream regulatory elements for these DEGs
The motif finding of transcription factor in promoter region of the core genes showed that three transcription factors were predicted in upregulated genes and eight transcription factors were in downregulated core genes (Table 6 ). Combining with the analyzing result of gene expression profile, transcription factor GATA2 was differentially expressed in lung adenocarcinoma tissues. Besides, statistics result indicated that the ratio of GATA2 with abnormal expression in cancer tissues was 67.4% (56/83) of all included samples, whereas the result of motif finding in core downregulated genes suggested that a known tumor suppressor gene homeobox A5 (HOXA5) was identified, and its motif feature was obviously enriched in these core downregulated genes. However, there was no other transcription factors differentially expressed in lung adenocarcinoma tissues.
Detection of fusion genes Gene fusion is a widespread phenomenon in tumor tissues and the recombination of exon fragments of different genes could result in dysfunction. 28 Tophat-fusion tool was used to detect the fusion genes in all RNA-seq database of six lung adenocarcinoma samples. In total, seven fusion gene loci were defined and shown in Table 7 ; these seven fusion loci distributed only in three patients and there were four corresponding fusion genes belonging to the human leukocyte antigen (HLA) family by combining with the functions of the fusion region. The HLA members, including HLA-A, HLA-B, HLA-C, HLA-G, HLA-DRB5, HLADRB6 and HAL-DQB1, were involved in gene fusion. In addition, gene fusion of short fragments was found both in LA_4 and LA_5 patients and both pointed to collagen-a1 type 1 (COL1A1), whose product was collagen, which was referred to skeleton of extracellular matrix. In addition, the fusion of FCGR2A (Fc fragment of IgG low-affinity IIa receptor)-FCGR2C only existed in tumor tissues of the LA_5 patient, and FCGR2A and FCGR2C belonged to immunoglobulin Fc receptor family, which mainly participated in phagocytosis and clearing of immune complexes. Binding with the information of fusion genes in the Catalogue of Somatic Mutations in Cancer database, 29 only the fusion records of COL1A1-USP6 (ubiquitin-specific peptidase 6) and COL1A1-PDGFB (platelet-derived growth factor b-polypeptide) were found, Down  33  AKAP12, BMP2, CAV1, CAV2, CBFA2T3, CDH13, CDH19, CMTM5,  CNTN6, CSRNP1, CYGB, DAB2IP, DLC1, FBLN1, HIC1, HYAL1, ID4, KL,  KLF10, KLF4, LATS2, NDRG2, NR4A1, NR4A3, PECAM1, SASH1,  SEMA3B, SLIT2, SPN, STARD8, TENC1, THSD1, TNS1   13  CXCL3, EGR1, ERG, FOSB, GAS6, ID1,  JUNB, JUND, MAFF, PDGFB, RAB40A,  RECK, TIMP3 Up 6 AURKB, ESRP1, LRIG3, SPINT2, UHRF1, XDH 3 MUC20, MYBL2, NME1 
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and integration of COL1A1 itself leading to exon fragment missing was not observed. Moreover, the functional analysis of fusion genes was performed and the products of all fusion genes were located on the cell membrane. Meanwhile, all genes were involved in cellular immune responses except for COL1A1. This result showed that the antigenic characteristics of lung adenocarcinoma cell surface changed and prevented lung adenocarcinoma cells from discovering by organism immune mechanism, to further complete the cell proliferation of lung adenocarcinoma.
DISCUSSION
In this research, we screened out the DEGs and core DEGs in the lung adenocarcinoma tissues by comparing with control samples and performed the functional analysis. The downregulated DEGs were closely related to vasculature development, cell adhesion and cell proliferation, whereas the upregulated DEGs significantly involved in regulation and activation of mitosis. This suggested that cell mitosis was inhibited in lung adenocarcinoma, while cell proliferation and vasculature development were positively related to lung adenocarcinoma.
Furthermore, 543 core DEGs were screened out by combining with another RNA-seq data, and their potential functions were annotated. After cytological position analysis, eight specifically high-expression genes were screened out, such as WISP1 and RAMP1 hardly expressed in normal tissue, but both were specially expressed factors in lung adenocarcinoma tissue. In fact, WISP1 is a cysteine-rich secreted factor belonging to the CCN family and it could participate in the inhibition of metastasis 30 and in the development and progression of primary lung cancers. 31 It was also essential for the metastatic process and specifically for pulmonary metastases. 32 For RAMP1, its expression was increased in cancer cells, 33 and the role of RAMP1 was reported to be a promotor in prostate tumorigenesis and as a novel biomarker, and possible therapeutic target in prostate cancer. 34 Thus, WISP1 and RAMP1 could be the potential candidates of biopsy indexes and potential therapy targets of lung adenocarcinoma.
In addition, in this research, through analyzing the function of core genes, MYBL2 was not only an oncogene, but also had transcription regulatory function, and its expression was upregulated in lung adenocarcinoma tissues. As we all know, MYBL2, a member of g-MYB-related oncogenes, was independently amplified in a small fraction of breast cancers. 35, 36 It was identified in the cell cycle pathway in lung cancer. 37, 38 Thus, MYBL2 might associate with the cell proliferation in lung adenocarcinoma, and could regulate the expression of relevant genes, whereas the specific function was unclear.
Besides, after motif-finding for the core DEGs, we found only GATA2 and HOXA5 differentially expressed in lung adenocarcinoma tissues among these transcription factors. We supposed that GATA2 was a transcription inhibitor, as GATA2 was upregulated in normal state, leading to inhibit the transcription of downstream genes combining with the promoter region of target genes, whereas in lung adenocarcinoma downregulated GATA2 led to the abnormal activation of downstream genes, further to induce the relevant promotion of the genes in cell cycle and enhance the cell proliferation. In previous studies, GATA2 loss dramatically reduced tumor development in a Kras-driven nonsmall cell lung cancer mouse model, 39 as well as in prostate cancer. 40 In addition, loss of expression or overexpression of GATA was associated with a variety of cancers in humans, such as breast cancer and gastrointestinal cancers. 41 Hence, GATA2 could be a new therapy target for lung adenocarcinoma. For HOXA5, it was downregulated among core genes, while previous research indicated that HOXA5 was upregulated in primary tumors. 42 Besides, expression levels of HOXA5 in squamous cell carcinoma tissues and adenocarcinoma tissues were also significantly higher than in the non-cancerous tissues. 43 Moreover, no significant decrease of HOXA5 expression occurred during lung development and HOXA5 remained highly expressed in the lungs of newborn animals. 44 Hence, the potential effects of abnormal expression of HOXA5 in lung adenocarcinoma were uncertain.
Moreover, the detection of fusion genes revealed that four fusion genes were identified in the HLA family. In previous studies, HLA-G expression in lung cancer was supposed to be one of the ways how the tumor downregulates host immune response. 45 Moreover, HLA class I antigen defects were frequently present in head and neck squamous cell carcinoma cells may provide the tumor with an escape mechanism from immune surveillance. 46 Thus, we thought the fusion of HLA family might lead to the abnormal characteristics of HLA proteins, to further trigger the defects of immune mechanism.
In conclusion, based on the DEGs and core genes, we obtained using RNA-seq data analysis; some DEGs were identified possessing the crucial functions on the development of lung adenocarcinoma, such as WISP1, RAMP1, MYBL2 and GATA2. These genes could be potential targets for treating lung adenocarcinoma and the fusion of HLA family genes might have important roles in lung adenocarcinoma. However, these results need to be further confirmed with more experiments. 
